The following income statement items appeared on the adjusted trial balance of Foxworthy Corporation for the year ended December $31,2024($$ in $000$s$)$: sales revenue, $$21,700$; cost of goods sold, $$14,200$; selling expense, $$2,240$; general and administrative expense, $$1,140$; dividend revenue from investments, $$140$; interest expense, $$240.$ Income taxes have not yet been accrued. The company$$s income tax rate is $25\%$ on all items of income or loss. These revenue and expense items appear in the company$$s income statement every year. The company$$s controller, however, has asked for your help in determining the appropriate treatment of the following nonrecurring transactions that also occurred during $2024($$ in $000$s$).$ All transactions are material in amount.

Investments were sold during the year at a loss of $$240.$ Foxworthy also had an unrealized loss of $$140$ for the year on investments. The unrealized loss represents a decrease in the fair value of debt securities and is classified as part of other comprehensive income.

One of the company$$s factories was closed during the year. Restructuring costs incurred were $$1,400.$

During the year, Foxworthy completed the sale of one of its operating divisions that qualifies as a component of the entity according to GAAP regarding discontinued operations. The division had incurred operating income of $$740$ in $2024$ prior to the sale, and its assets were sold at a loss of $$1,920.$

A positive foreign currency translation adjustment for the year totaled $$660.$

Required:

Prepare Foxworthy$$s single, continuous statement of comprehensive income for $2024,$ including earnings per share disclosures. Use a multiple$-$step income statement format. Three million shares of common stock were outstanding throughout the year.